Thomas M. Moran

Parvalbumin-containing interneurons in rat hippocampus have an AMPA receptor profile suggestive of vulnerability to excitotoxicity.

Immune responses to viruses, bacteria, parasites and fungi in humans.

Antiviral immunity and the role of dendritic cells.

Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC.

Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses.

Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus.

Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein.

The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen.

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.

TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.

Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.

Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops.

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.

Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins.

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.

Toll-like receptor-independent triggering of dendritic cell maturation by viruses.

Sendai virus infection induces efficient adaptive immunity independently of type I interferons.

Influenza virus evades innate and adaptive immunity via the NS1 protein.

A novel role for viral-defective interfering particles in enhancing dendritic cell maturation.

A novel model of demyelinating encephalomyelitis induced by monocytes and dendritic cells.

Cytokine-independent upregulation of MDA5 in viral infection.

Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells.

A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.

MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles.

The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.

A comprehensive evaluation of human plasmacytoid dendritic cells using small volumes of human blood.

Estrogen inhibits dendritic cell maturation to RNA viruses.

Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus.

Antiviral-activated dendritic cells: a paracrine-induced response state.

Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity.

The functional impairment of natural killer cells during influenza virus infection.

IL-11 regulates autoimmune demyelination.

Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.

Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells.

The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells.

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.

Antiviral instruction of bone marrow leukocytes during respiratory viral infections.

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.

Peripheral blood cytokine profiling during pregnancy and post-partum periods.

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.

Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen.

The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Buying time-the immune system determinants of the incubation period to respiratory viruses.

Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection.

p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus.

Characterizing the Pregnancy Immune Phenotype: Results of the Viral Immunity and Pregnancy (VIP) Study.